Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0001473,
umls-concept:C0001613,
umls-concept:C0005456,
umls-concept:C0005558,
umls-concept:C0007776,
umls-concept:C0022655,
umls-concept:C0029904,
umls-concept:C0086418,
umls-concept:C0178587,
umls-concept:C0220825,
umls-concept:C0228174,
umls-concept:C0301630,
umls-concept:C0443224,
umls-concept:C0497327,
umls-concept:C0597484
|
pubmed:issue |
4
|
pubmed:dateCreated |
1997-3-14
|
pubmed:abstractText |
Na+,K(+)-ATPase density in human cerebral cortex was for the first time studied by vanadate facilitated [3H]ouabain binding to intact samples. Fresh human cerebral cortical biopsies were obtained as a result of diagnostic frontal lobe biopsy from patients with normal pressure hydrocephalus (NPH) syndrome and associated dementia. For control measurements post-mortem samples were obtained from patients without clinically observed dementia. [3H]ouabain binding kinetics were evaluated: when incubating samples in 1 microM [3H]ouabain binding equilibrium was obtained after 6 h of incubation, non-specific uptake and retention amounted to only 2.3% of total uptake and retention of [3H]ouabain and release of specifically bound [3H]ouabain during washout in the cold occurred only slowly (T1/2 = 37 h). Evaluation of receptor affinity for ouabain was in agreement with a heterogeneous population of [3H]ouabain binding sites. [3H]Ouabain binding was significantly reduced after frozen storage of samples before measurements. Post-mortem degradation of cerebral [3H]ouabain binding sites occurred only slowly (T1/2 = 75 h). No significant variation in [3H]ouabain binding site density was observed between the cerebral lobes with occipital, parietal and temporal values (means +/- S.E.M., n = 5) amounting to 10281 +/- 649, 11267 +/- 1011 and 9263 +/- 615 pmol/g wet wt., respectively. [3H]Ouabain binding measured in frontal cortical samples gave values of (means +/- S.E.M., n = 5) 4274 +/- 1020 and 11397 +/- 976 pmol/g wet wt. delta % = 62; P < 0.05) in patients with dementia and controls, respectively. Human cerebral cortical capacity for active K+ uptake was around 37- and 16-fold greater than in skeletal muscular and myocardial tissue, respectively.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0926-6410
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
281-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8957569-Aged,
pubmed-meshheading:8957569-Binding Sites,
pubmed-meshheading:8957569-Cerebral Cortex,
pubmed-meshheading:8957569-Dementia,
pubmed-meshheading:8957569-Female,
pubmed-meshheading:8957569-Humans,
pubmed-meshheading:8957569-Male,
pubmed-meshheading:8957569-Middle Aged,
pubmed-meshheading:8957569-Ouabain,
pubmed-meshheading:8957569-Sodium-Potassium-Exchanging ATPase
|
pubmed:year |
1996
|
pubmed:articleTitle |
Reduction of cerebral cortical [3H]ouabain binding site (Na+,K(+)-ATPase) density in dementia as evaluated in fresh human cerebral cortical biopsies.
|
pubmed:affiliation |
Department of Medicine B 2142, Rigshospitalet, National University Hospital, Copenhagen, Denmark.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|